Lightcalls.com
 

In Western tillages garlic is used...

In Western tillages garlic is used for the prevention of or in the treatment of disease conditions, as it was as high blood pressure, atherosclerosis and high cholesterol all more prevalent in industrialized, bring outed societies.

If one herb is the two a culinary favorite and a medicinal treasure chest unto itself, it is garlic, Allium sativum. Garlic is known the world across as both food and medicine, a position it has occupied in human life for throughout 5,000 years.

Modern use of garlic is frequently determined by cultural perspective. In China, for example, garlic is called da-suan. While known as an edible plant since before recorded history, the first record of garlic's medicinal use in China appears in Tao Hongjing's Ming Yi Bei Lu (Miscellaneous Records of Famous Physicians), published during the era of the North and southern Dynasties, around 91,0 A.D.

In fresh China, garlic is considered a folk medicine used by much, of the population, rather than an official drug" plant. However, the use of garlic has remained essentially the same across the centuries, as it is the same of the best known treatments for bloody flux caused by bacteria or other microorganisms. in Thailand, the protuberances are often used as a first line of treatment for skin diseases, as well as for cough lung abscesses and other related conditions. In India, garlic is considered a powerful, natural disinfectant and internal cleansing herb. It is used as an antibacterial in intestinal disorders, as well as for a number of infectious diseases.



Garlic therapy has equal been used in the treatment of leprosy In developing countries around the world, it is clear that garlic is used for serious disease conditions, that would be treated with conventional mix with drugss in Western medicine.

In Western agricultures garlic is used for the prevention of or in the treatment of disease conditions more prevelant in industrialized, unfolded societies. It is valued for its hypocholesterolemic (cholesterol-lowering) tenor and for its antiatherosclerotic vascular plaque-fighting) consequences along with antiplatelet aggregation (anti-blood clumping), line thinning and fibrinolytic (clot-dissolving) activities.

A biological overview of our arteries and their cells

Our inner arterial walls are compos of sum of two units types of cells. One pattern called atherophils, is capable of accumulating fat. Atherophils will absorb fat when various factors are existing such as high cholesterol, high progeny pressure or abnormal permeability of veins. one time the fat begins to garner it can spread to neighboring lonely dwellings and may cause cellular degeneration as it continues to accumulate. This proces begins to destroy high amounts of oxygen, increasing metabolism at the site. The changes take place where collagen fibers are produc by way of fibrocytes.

Other compounds, such as mucopolysaccharides, begin to build at the collagen fibers, causing the inner lining of the veins to thicken. As the proces builds through time, atherosclerotic plaque builds in the confined apartment walls, then extends to the muscle tissue onward the middle layer of the vein or artery.

Consequently the kin in the veins is slowed down. The ultimate come can be blockage, where the plaque breaks facing and causes clotting.

Numerous studies, involving one as well as the other animals and humans, have demonstrated the ability of garlic preparations to inhibit adhesion and aggregation, which then follows in decreased risk to factors leading to hardening of the arteries. Garlic's ability to inhibit platelet aggregation has been shown to be influenced by way of the utilization of arachidonic acid, an unsaturated.

A number of pay with an abatements in a variety of different garlic preparations, including methyl-allyltrisulfide, dialyltrisulfide, allicin and ajoene have all been shown to be involved in antithrombotic (antistroke) and anti-blood-clumping activities, resulting in offspring moving more freely in line vessels. Garlic's ability to lower life-current sugar levels, while increasing the concentration of glycogen (carbohydrate reserve) and exempt fatty acids in the liver, has also been shown to contribute to garlic's multi-faceted biological activity.

Garlic's purports on cholesterol -- a major area of study

One of the major areas in which garlic preparations have been studied in human clinical trials is its import on cholesterol and low-density lipoprotein cholesterol (LDL the "bad" kind). A newly come review by German phytomedicine specialist, HD Reuter in eau-de-cologne summarizes the results of 28 clinical studies.

These studies were evaluated using various factors, including their initial design, number of patients involved, duration of treatment, models of garlic preparations used, dosages and criterioned effects. In these wide range of studies, with treatment durations lasting from several weeks to several month when considered collectively, the garlic preparations showed a mean decrease in cholesterol plains of 10.3 percent.

The studies included as well-as; not only-but also; not only-but; not alone-but placebo-controlled and open studies. Various assemblages of patients were involved, including healthy clan those with hyperlipidemia, patients with hypercholesterolemia, those suffering from hypertension, coronary heart disease, arterial occlusive disease, and others.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.